2008
DOI: 10.1002/pbc.21787
|View full text |Cite
|
Sign up to set email alerts
|

Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy

Abstract: We report a high incidence of vascular abnormalities in children with craniopharyngioma. The data suggest that intracystic bleomycin may contribute to radiation-related vasculopathy. We now include magnetic resonance angiography as part of our routine follow up in these children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
38
0
2

Year Published

2010
2010
2016
2016

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(40 citation statements)
references
References 14 publications
0
38
0
2
Order By: Relevance
“…The authors suggested that these numbers might be higher with longer follow up. A single institution review found that 6 of 20 children had imaging evidence of vasculopathy, half of whom were symptomatic [27]. Of note, two of these children also had intracystic bleomycin, which also could have contributed to vascular risk.…”
Section: Risk Factorsmentioning
confidence: 99%
“…The authors suggested that these numbers might be higher with longer follow up. A single institution review found that 6 of 20 children had imaging evidence of vasculopathy, half of whom were symptomatic [27]. Of note, two of these children also had intracystic bleomycin, which also could have contributed to vascular risk.…”
Section: Risk Factorsmentioning
confidence: 99%
“…Liu et al 22 re ported on 6 patients in a series of 20 who developed a vasculopathy on neuroimaging after receiving radiation therapy for craniopharyngioma. Retrospective studies of radiation therapy directed at the sellar/suprasellar region have demonstrated an incidence as high as 21% for cere brovascular events.…”
Section: Cerebrovascular Diseasementioning
confidence: 99%
“…The risk of radiation injury depends on the dose (either total dose or per fraction), duration of treatment, and volume of normal brain irradiated (Regine et al, 1993;Chung et al, 1998;Chakrabarti et al, 2005;Kobayashi et al, 2005;Adler Jr. et al, 2006;Liu et al, 2009;Campbell et al, 2010;Hasegawa et al, 2010).…”
Section: Complications Of Radiation Therapymentioning
confidence: 99%